IP Library › Granted Patent US 12,606,766
Granted Patent B2
US 12,606,766 · App. 18/431,334 · Granted Apr 21, 2026

Multipurpose oxypyridinones and their functional use-4

Inventors: David R. Coultas (Oxford, GB); Joanne Tory (Didcot, GB); Abby Casey (Oxford, GB)
Assignee: INFINEUM INTERNATIONAL LIMITED
C10M133/40C10M101/00C10M163/00C10M2203/1085C10M2215/221C10N2010/12C10N2020/02C10N2030/12C10N2050/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,606,766
App. No.
18/431,334
Granted
Apr 21, 2026
Kind
B2
Abstract

A composition is provided to comprise a non-aqueous medium and a 3,4-oxypyridine compound of structure (I): with each A being oxygen and/or sulfur, and with a variety of substituents at R 1 -R 5 to enable a solution or an at least semi-stable emulsion to be formed in the non-aqueous medium. Methods of use are included herein, which may be focused on situations where the composition can be used as a lubricant and/or coolant.

Claims (65)

1 . A lubricant composition comprising:

a Group I, Group II, Group III, Group IV, and/or Group V lubricating oil basestock;

a compound of structure (I):

wherein:

each A is individually an oxygen atom, a sulfur atom, an oxymethyl (—CH 2 —O—) moiety, or a methylthio (—CH 2 —S—) moiety;

R 1 is hydrogen; an ammonium ion; a C 1 -C 6 monoalkylammonium ion; a C 1 -C 6 dialkylammonium ion; a C 1 -C 6 trialkylammonium ion; a C 1 -C 6 tetraalkylammonium ion; a C 1 -C 6 monoalkylsilyl moiety; a C 1 -C 6 dialkylsilyl moiety; a C 1 -C 6 trialkylsilyl moiety; an optionally substituted aryl, alkyl, alkaryl, or aralkyl sulfonyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyl sulfide; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 20 moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an ester-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioester-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a linear, branched, and/or cyclic C 1 -C 20 acyl moiety; a linear, branched, and/or cyclic C 1 -C 20 thioacyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyloxyacyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyloxythioacyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbylthiocarbonyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbylthio-thioacyl moiety; an amide-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioamide-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a ketone-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioketone-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioaldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a mercaptan-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a hydroxyl-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a nonionic linear, branched, and/or (hetero) cyclic moiety containing 1 to 20 carbon atoms at least one nitrogen atom, and optionally at least one sulfur and/or oxygen atom; or another compound of structure (I) connected as an ether or thioether at a meta position to the ring nitrogen thereof;

R 2 is hydrogen; a halogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 12 moiety; an amine-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a hydroxyl-containing linear, branched, and/or cyclic C 1 -C 12 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; or a nitrile-containing linear, branched, and/or cyclic C 1 -C 20 moiety;

R 3 is hydrogen; a halogen; or a linear, branched, and/or cyclic C 6 -C 24 hydrocarbyl moiety;

R 4 is hydrogen; a halogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 12 moiety; an amine-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a hydroxyl-containing linear, branched, and/or cyclic C 1 -C 12 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; or a nitrile-containing linear, branched, and/or cyclic C 1 -C 20 moiety; and

R 5 is hydrogen; a halogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 12 moiety; a hydroxylated linear, branched, and/or cyclic C 1 -C 6 moiety; or an R 1 -A-moiety;

or alternatively one or more of R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , and R 4 and R 5 may together form one or more (hetero) cyclic rings;

with the proviso that R 1 and R 3 are not both hydrogen; and

either:

an optionally substituted triazole corrosion inhibitor, an optionally substituted benzotriazole corrosion inhibitor, an optionally substituted thiadiazole, an optionally substituted thiadiazole corrosion inhibitor, an ashless dihydrocarbyl dithiocarbamate, a C 8 -C 18 acrylate, a C 2 -C 6 dialkylene glycol diester, a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor, or a combination thereof; or

substantially none of the following: an optionally substituted triazole corrosion inhibitor; an optionally substituted benzotriazole corrosion inhibitor; an optionally substituted thiadiazole corrosion inhibitor; an ashless dihydrocarbyl dithiocarbamate; a C 8 -C 18 acrylate; a C 2 -C 6 dialkylene glycol diester; and a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor; and

at least one additional lubricant additive selected from the group consisting of a calcium- and/or magnesium-containing detergent, an ashless dispersant, an additional corrosion inhibitor, an antioxidant, a friction modifier, an antiwear agent, an antifoamant, a viscosity modifier, a pour point depressant, a tackifier, a demulsifier, an extreme pressure agent, a seal swell agent, and a combination thereof.

2 . The composition of claim 1 , wherein the lubricating oil basestock comprises a Group I, Group II, and/or Group III lubricating oil basestock.

3 . The composition of claim 1 , wherein:

all A's are oxygen atoms;

R 1 is hydrogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 12 moiety; or another 3,4-oxypyridinone connected as an ether at a meta position to the ring nitrogen thereof;

R 2 is hydrogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 12 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 12 moiety; or a nitrile-containing linear, branched, and/or cyclic C 1 -C 12 moiety;

R 3 is a linear, branched, and/or cyclic C 8 -C 20 hydrocarbyl moiety;

R 4 is hydrogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 12 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 12 moiety; or a nitrile-containing linear, branched, and/or cyclic C 1 -C 12 moiety; and

R 5 is hydrogen; or an R 1 -A-moiety;

or R 4 and R 5 together comprise from 3 to 12 carbons and form a (hetero) cyclic ring structure.

4 . A lubricant composition comprising the composition of claim 1 , wherein the at least one lubricant additive comprises:

an optionally substituted diaryl amine antioxidant, a hindered phenol antioxidant, or both, wherein, when both are present, a weight ratio of the compound of structure (I) to a sum of the optionally substituted diaryl amine and hindered phenol antioxidants is from 10:1 to 1:10;

a zinc dialkyldithiophosphate antiwear agent, an organic friction modifier, or both;

substantially no molybdenum-containing friction modifier;

an additional corrosion inhibitor comprising an optionally substituted triazole corrosion inhibitor, an optionally substituted benzotriazole corrosion inhibitor, an optionally substituted thiadiazole corrosion inhibitor, an ashless dihydrocarbyl dithiocarbamate, a C 8 -C 18 acrylate, a C 2 -C 6 dialkylene glycol diester, a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor, or a combination thereof; and/or

a multi-arm star viscosity modifier, an olefin copolymer viscosity modifier, a hydrogenated diene block copolymer viscosity modifier, a polystyrene copolymer viscosity modifier, a poly(meth)acrylate viscosity modifier, a poly(dialkyl fumarate)-based viscosity modifier, a poly(vinyl acyl ester)-based viscosity modifier, or a combination or copolymer thereof.

5 . The lubricant composition of claim 1 , wherein the at least one lubricant additive comprises a molybdenum-containing friction modifier.

6 . A method of inhibiting and/or mitigating copper and/or lead corrosion on a powertrain surface exposed to a composition, the method comprising incorporation of an amount of a compound of structure (I), or via formation of an effective complex or reaction product thereof, to attain the composition of claim 1 and/or at the powertrain surface, wherein the composition comprises an optionally substituted triazole corrosion inhibitor, an optionally substituted benzotriazole corrosion inhibitor, an optionally substituted thiadiazole corrosion inhibitor, an ashless dihydrocarbyl dithiocarbamate, a C 8 -C 18 acrylate, a C 2 -C 6 dialkylene glycol diester, a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor, or a combination thereof.

7 . A method to inhibit and/or mitigate copper and/or lead corrosion on a powertrain surface comprising exposing the powertrain surface to the non-aqueous composition of claim 1 , or a complex or reaction product thereof, wherein the composition comprises an optionally substituted triazole corrosion inhibitor, an optionally substituted benzotriazole corrosion inhibitor, an optionally substituted thiadiazole corrosion inhibitor, an ashless dihydrocarbyl dithiocarbamate, a C 8 -C 18 acrylate, a C 2 -C 6 dialkylene glycol diester, a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor, or a combination thereof.

8 . A method of inhibiting and/or mitigating copper and/or lead corrosion on a powertrain surface exposed to a composition, the method comprising incorporation of an amount of a compound of structure (I), or via formation of an effective complex or reaction product thereof, to attain the composition of claim 1 and/or at the powertrain surface, wherein the composition comprises substantially none of the following: an optionally substituted triazole corrosion inhibitor; an optionally substituted benzotriazole corrosion inhibitor; an optionally substituted thiadiazole corrosion inhibitor; an ashless dihydrocarbyl dithiocarbamate; a C 8 -C 18 acrylate; a C 2 -C 6 dialkylene glycol diester; and a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor.

9 . A method to inhibit and/or mitigate copper and/or lead corrosion on a powertrain surface comprising exposing the powertrain surface to the non-aqueous composition of claim 1 , or a complex or reaction product thereof, wherein the composition comprises substantially none of the following: an optionally substituted triazole corrosion inhibitor; an optionally substituted benzotriazole corrosion inhibitor; an optionally substituted thiadiazole corrosion inhibitor; an ashless dihydrocarbyl dithiocarbamate; a C 8 -C 18 acrylate; a C 2 -C 6 dialkylene glycol diester; and a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor.

10 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I) and a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor (and optionally also comprising: a calcium-containing detergent and substantially no magnesium-containing detergent; and/or a calcium salicylate detergent), and when subject to a high temperature corrosion bench test (HTCBT) at ˜135° C. according to ASTM D6594, exhibits a dissolved copper level after 168 hours of no more than 25 ppm Cu and a dissolved lead level after 168 hours of no more than 100 ppm Pb.

11 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I) and an optionally substituted triazole corrosion inhibitor and/or an optionally substituted benzotriazole corrosion inhibitor (and optionally also comprising: a calcium-containing detergent and substantially no magnesium-containing detergent; and/or a calcium salicylate detergent), and when subject to a high temperature corrosion bench test (HTCBT) at ˜135° C. according to ASTM D6594, exhibits a dissolved copper level after 168 hours of no more than 25 ppm Cu and a dissolved lead level after 168 hours of no more than 140 ppm Pb.

12 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I) and one or more of an ashless dihydrocarbyl dithiocarbamate, a C 8 -C 18 acrylate, and a C 2 -C 6 dialkylene glycol diester (and optionally also comprising a calcium salicylate detergent), and when subject to a high temperature corrosion bench test (HTCBT) at ˜135° C. according to ASTM D6594, exhibits a dissolved copper level after 168 hours of no more than 25 ppm Cu and a dissolved lead level after 168 hours of no more than 140 ppm Pb.

13 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I) and substantially none of an optionally substituted triazole corrosion inhibitor, an optionally substituted benzotriazole corrosion inhibitor, an optionally substituted thiadiazole corrosion inhibitor, an ashless dihydrocarbyl dithiocarbamate, a C 8 -C 18 acrylate, a C 2 -C 6 dialkylene glycol diester, and a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor (and optionally further comprising one or more of a calcium salicylate detergent, a combination of magnesium- and calcium-containing detergents, substantially no sulfonate detergents, substantially no molybdenum friction modifier, a zinc dihydrocarbyl dithiophosphate antiwear agent in which the hydrocarbyl groups are connected to the dithiophosphate moiety via secondary carbon atoms, and at least one boron-containing compound), and when subject to a high temperature corrosion bench test (HTCBT) at ˜135° C. according to ASTM D6594, exhibits a dissolved copper level after 168 hours of no more than 25 ppm Cu and a dissolved lead level after 168 hours of no more than 140 ppm Pb.

14 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I), a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor, and either an optionally substituted triazole corrosion inhibitor or an optionally substituted benzotriazole corrosion inhibitor, and when subject to a Sequence VIII engine test according to ASTM D6709, exhibits:

an adjusted bearing weight loss from-3% to +50% below an adjusted bearing weight loss from a comparative composition under identical test conditions; and

a stripped viscosity at ˜100° C. of no more than 2.5% above a stripped viscosity at ˜100° C. from a comparative composition under identical test conditions,

wherein the comparative composition comprises substantially none of the 3,4-oxypyridinone compound of structure (I), substantially none of the tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor, and substantially none of either the optionally substituted triazole corrosion inhibitor or the optionally substituted benzotriazole corrosion inhibitor.

15 . A method of inhibiting and/or mitigating total acid number (TAN) increase over a time period, with no more than 7% change in total base number (TBN) over the same time period, in a composition, the method comprising incorporation of an amount of a compound of structure (I) in claim 1 to the composition, or formation of an effective complex or reaction product thereof in the composition, wherein the composition comprises substantially none of the following: an optionally substituted triazole corrosion inhibitor; an optionally substituted benzotriazole corrosion inhibitor; an optionally substituted thiadiazole corrosion inhibitor; an ashless dihydrocarbyl dithiocarbamate; a C 8 -C 18 acrylate; a C 2 -C 6 dialkylene glycol diester; and a tri-hydrocarbyl C 1 -C 8 borate corrosion inhibitor and wherein the oxypyridinone compound of structure (I) is represented by the structure:

wherein:

each A is individually an oxygen atom, a sulfur atom, an oxymethyl (—CH 2 —O—) moiety, or a methylthio (—CH 2 —S—) moiety;

R 1 is hydrogen; an ammonium ion; a C 1 -C 6 monoalkylammonium ion; a C 1 -C 6 dialkylammonium ion; a C 1 -C 6 trialkylammonium ion; a C 1 -C 6 tetraalkylammonium ion; a C 1 -C 6 monoalkylsilyl moiety; a C 1 -C 6 dialkylsilyl moiety; a C 1 -C 6 trialkylsilyl moiety; an optionally substituted aryl, alkyl, alkaryl, or aralkyl sulfonyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyl sulfide; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 20 moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an ester-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioester-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a linear, branched, and/or cyclic C 1 -C 20 acyl moiety; a linear, branched, and/or cyclic C 1 -C 20 thioacyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyloxyacyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbyloxythioacyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbylthiocarbonyl moiety; a linear, branched, and/or cyclic C 1 -C 20 hydrocarbylthio-thioacyl moiety; an amide-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioamide-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a ketone-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioketone-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a thioaldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a mercaptan-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a hydroxyl-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a nonionic linear, branched, and/or (hetero) cyclic moiety containing 1 to 20 carbon atoms at least one nitrogen atom, and optionally at least one sulfur and/or oxygen atom; or another compound of structure (I) connected as an ether or thioether at a meta position to the ring nitrogen thereof;

R 2 is hydrogen; a halogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 12 moiety; an amine-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a hydroxyl-containing linear, branched, and/or cyclic C 1 -C 12 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; or a nitrile-containing linear, branched, and/or cyclic C 1 -C 20 moiety;

R 3 is hydrogen; a halogen; or a linear, branched, and/or cyclic C 6 -C 24 hydrocarbyl moiety;

R 4 is hydrogen; a halogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 12 moiety; an amine-containing linear, branched, and/or cyclic C 1 -C 20 moiety; an ether-containing linear, branched, and/or cyclic C 1 -C 20 moiety; a hydroxyl-containing linear, branched, and/or cyclic C 1 -C 12 moiety; an aldehyde-containing linear, branched, and/or cyclic C 1 -C 20 moiety; or a nitrile-containing linear, branched, and/or cyclic C 1 -C 20 moiety; and

R 5 is hydrogen; a halogen; a linear, branched, and/or cyclic C 1 -C 12 hydrocarbyl moiety; an at least partially halogenated linear, branched, and/or cyclic C 1 -C 12 moiety; a hydroxylated linear, branched, and/or cyclic C 1 -C 6 moiety; or an R 1 -A-moiety;

or alternatively one or more of R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , and R 4 and R 5 may together form one or more (hetero) cyclic rings;

with the proviso that R 1 and R 3 are not both hydrogen.

16 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I) (and optionally also comprising a zinc dihydrocarbyl dithiophosphate antiwear agent, a molybdenum-containing friction modifier, and a salicylate detergent), and when subject to a Sequence X timing chain wear test for at least 216 hours according to ASTM D8279, exhibits:

for times from 120 hours to 216 hours, a decrease in TAN value, as measured according to ASTM D664, of at least 1.0 mg KOH/g below a TAN value from a comparative composition that was subject to the Sequence X timing chain wear test for an identical time period; and

(i) a difference in TBN value, as measured according to ASTM D4739, at end of test that is no more than 0.5 mg KOH/g above or below a TBN value from a comparative composition that was subject to the diesel engine oxidation test for an identical time period, and/or (ii) a difference in TBN value, as measured according to ASTM D4739, at any time during the test that is no more than 1.0 mg KOH/g above or below a TBN value from a comparative composition that was subject to the Sequence X timing chain wear test for an identical time period,

wherein the comparative composition comprises substantially none of the compound of structure (I) but is otherwise identical to the lubricant composition.

17 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I) (and optionally also comprising a zinc dihydrocarbyl dithiophosphate antiwear agent, a molybdenum-containing friction modifier, and a salicylate detergent), and when subject to a Sequence IVB valve train wear test for ˜200 hours according to ASTM D8350, exhibits:

for times of at least 175 hours, a decrease in TAN value, as measured according to ASTM D664, of at least 1.2 mg KOH/g below a TAN value from a comparative composition that was subject to the Sequence IVB valve train wear test for an identical time period; and/or

(i) a difference in TBN value, as measured according to ASTM D4739, at end of test that is no more than 0.5 mg KOH/g above or below a TBN value from a comparative composition that was subject to the Sequence IVB valve train wear test for an identical time period, and/or (ii) a difference in TBN value, as measured according to ASTM D4739, at times of at least 25 hours that are each no more than 1.0 mg KOH/g above or below a TBN value from a comparative composition that was subject to the Sequence IVB valve train wear test for an identical time period,

wherein the comparative composition comprises substantially none of the compound of structure (I) but is otherwise identical to the lubricant composition.

18 . A lubricant composition comprising the composition of claim 1 , wherein the lubricant composition comprises the compound of structure (I), and when subject to one or more of (a) an oxidation test in a heavy exhaust gas recycle (EGR) diesel engine with variable geometry turbocharging (VGT) for at least 360 hours, (b) a Sequence X timing chain wear test for at least 216 hours according to ASTM D8279, and/or (c) a Sequence IVB valve train wear test for ˜200 hours according to ASTM D8350, exhibits, at some time after TAN-TBN crossover and until end of test, a decrease in TAN value, as measured according to ASTM D664, that is at least 10% and/or at least 0.7 mg KOH/g below a TAN value from a comparative composition that was subject to the one or more tests for an identical time period, wherein:

TAN-TBN crossover represents the time during the test at which TBN values of both lubricant composition and comparative composition, measured according to ASTM D4739, exceed TAN values of both lubricant composition and comparative composition, respectively, by at least 3%, whereas both TAN values exceeded both TBN values by at least 3% at start of test (0 hours); and

the comparative composition comprises substantially none of the compound of structure (I) but is otherwise identical to the lubricant composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2025
From: COULTAS, DAVID; TORY, JOANNE; CASEY, ABBY
To: INFINEUM INTERNATIONAL LIMITED
Reel/Frame 072145/0109 →
Priority Claims (1)
EP 23157268 · Feb 17, 2023 · regional
Continuity (1)
Related Publication 20240294842A1 · Sep 5, 2024
References Cited (75)
US 2100993A · Bruson · 1937 [cited by applicant]
US 2719125A · Roberts · 1955 [cited by applicant]
US 2719126A · Fields et al. · 1955 [cited by applicant]
US 2760933A · Fields et al. · 1956 [cited by applicant]
US 2836564A · Roberts et al. · 1958 [cited by applicant]
US 3087937A · Tesi et al. · 1963 [cited by applicant]
US 3254025A · Le Suer · 1966 [cited by applicant]
US 3502677A · Le Suer · 1970 [cited by applicant]
US 3663561A · Blaha · 1972 [cited by applicant]
US 3697574A · Piasek et al. · 1972 [cited by applicant]
US 3703536A · Piasek et al. · 1972 [cited by applicant]
US 3704308A · Piasek et al. · 1972 [cited by applicant]
US 3751365A · Piasek et al. · 1973 [cited by applicant]
US 3756953A · Piasek et al. · 1973 [cited by applicant]
US 3798165A · Piasek et al. · 1974 [cited by applicant]
US 3803039A · Piasek et al. · 1974 [cited by applicant]
US 3843536A · Johnston · 1974 [cited by applicant]
US 4231759A · Udelhofen et al. · 1980 [cited by applicant]
US 4259194A · deVries et al. · 1981 [cited by applicant]
US 4259195A · King et al. · 1981 [cited by applicant]
US 4261843A · King et al. · 1981 [cited by applicant]
US 4263152A · King et al. · 1981 [cited by applicant]
US 4265773A · deVries et al. · 1981 [cited by applicant]
US 4272387A · King et al. · 1981 [cited by applicant]
US 4283295A · deVries et al. · 1981 [cited by applicant]
US 4285822A · deVries et al. · 1981 [cited by applicant]
US 4767551A · Hunt et al. · 1988 [cited by applicant]
US 4798684A · Salomon · 1989 [cited by applicant]
US 4857214A · Papay et al. · 1989 [cited by applicant]
US 5084197A · Galic et al. · 1992 [cited by applicant]
US 5242612A · Ryer et al. · 1993 [cited by applicant]
US 5326487A · Ryer et al. · 1994 [cited by applicant]
US 5534170A · Watts · 1996 [cited by applicant]
US 5840663A · Nibert et al. · 1998 [cited by applicant]
US 6323164B1 · Liesen et al. · 2001 [cited by applicant]
US 6432313B2 · Bruening et al. · 2002 [cited by applicant]
US 7491248B2 · Colucci et al. · 2009 [cited by applicant]
US 8048833B2 · Habeeb et al. · 2011 [cited by applicant]
US 8815789B2 · Tetard et al. · 2014 [cited by applicant]
US 8943910B2 · Addleman et al. · 2015 [cited by applicant]
US 9439984B2 · Raymond et al. · 2016 [cited by applicant]
US 9617541B2 · Mirkin et al. · 2017 [cited by applicant]
US 9677075B2 · Mirkin et al. · 2017 [cited by applicant]
US 9683195B2 · Nakada et al. · 2017 [cited by applicant]
US 9938479B2 · Lange et al. · 2018 [cited by applicant]
US 10731101B2 · Delamore et al. · 2020 [cited by applicant]
US 10899986B2 · Smith et al. · 2021 [cited by applicant]
US 20090005277A1 · Watts et al. · 2009 [cited by applicant]
US 20200354647A1 · Schwaebisch et al. · 2020 [cited by applicant]
US 20240287405A1 · Coultas · 2024 [cited by examiner]
US 20240294840A1 · Rogers-Simpson · 2024 [cited by examiner]
US 20240294841A1 · Coultas · 2024 [cited by examiner]
EP 4417672A1 · 2024 [cited by applicant]
EP 4417673A1 · 2024 [cited by applicant]
EP 4417674A1 · 2024 [cited by applicant]
EP 4417675A1 · 2024 [cited by applicant]
WO 9406897A1 · 1994 [cited by applicant]
WO WO0117497A1 · 2001 [cited by examiner]
WO 0142399A1 · 2001 [cited by applicant]
EP Form 1507W for related EP Application No. 24157623.0 dated Jun. 18, 2024. [cited by applicant]
EP Form 1507W for related EP Application No. 24157621.4 dated Jun. 18, 2024. [cited by applicant]
EP Form 1507W for related EP Application No. 24157627.1 dated Jun. 18, 2024. [cited by applicant]
EP Form 1507W for related EP Application No. 24157626.3 dated Jun. 18, 2024. [cited by applicant]
Hider, Robert C. et al., “The potential application of iron chelators for the treatment of neurodegenerative diseases”, Metallomics, 2011, vol. 3, pp. 239-249. [cited by applicant]
Campbell, Barbara K. et al., “Studies on [gamma]-Pyrones. II. Synthesis of 4-Piperidinols from Pyrones”, The Journal of Organic Chemistry, 1952, vol. 15, No. 2, pp. 331-342. [cited by applicant]
Zhang, Guangling et al., “Direct C3-alkenylation of pyridin-4(1H)-one via oxidative Heck coupling”, Tetrahedron, 2013, vol. 69, pp. 1115-1119. [cited by applicant]
Gagnon, M. Karen J. et al., “Synthesis and Hydroboration of Lipophilic Hydroxy-pyridinones and Their Complexes with Molybdenum (VI)”, Australian Journal of Chemistry, 2000, vol. 53, No. 8, pp. 693-697. [cited by applicant]
Gumbau-Brisa, R. et al., “Enhanced Fe3+ binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity”, Biometals, 2020, vol. 33, N… [cited by applicant]
American Petroleum Institute, “Engine Oil Licensing and Certification System”, Industry Services Department, API 1509, 1996 Fourteenth Edition, 1998 Addendum 1. [cited by applicant]
Smalheer, C.V. et al., “Lubricant Additives”, 1967, pp. 1-11. [cited by applicant]
Crisponi, Guido et al., “Iron chelating agents for the treatment of iron overload”, Coordination Chemistry Reviews, 2008, vol. 252, pp. 1225-1240. [cited by applicant]
Santos, M. Amelia, “Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications Mono and combined ligand approaches”, Coordination Chemistry Reviews, 2008, vol. 252, pp. 1213-1224. [cited by applicant]
Santos, M. Amelia, “Hydroxypyridinone complexes with aluminium. In vitro/vivo studies and perspectives”, Coordination Chemistry Reviews, 2002, vol. 228, pp. 187-203. [cited by applicant]
Crumbliss, Alvin L. et al., “Iron sequestration by small molecules: thermodynamic and kinetic studies of natural siderophores and synthetic model compounds”, Advances in Inorganic Chemistry, 2009, vol. 61, p. 179. [cited by applicant]
Liu, Zu D. et al., “Design of iron chelators with therapeutic application”, Coordination Chemistry Reviews, 2002, vol. 232, pp. 151-171. [cited by applicant]